06/11/2025
7:34 PM | Cherington Charles (Reporting)
Ernexa Therapeutics Inc. (Issuer)
Eterna Therapeutics (Issuer)
Ernexa Therapeutics Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2025
7:39 PM | Cherington Charles (Filed by)
Ernexa Therapeutics Inc. (Subject)
Eterna Therapeutics (Subject)
Ernexa Therapeutics Inc. (Subject)
| Form SCHEDULE 13D/A | |
06/11/2025
3:30 PM | Ernexa Therapeutics Inc. (Filer)
Eterna Therapeutics (Filer)
Ernexa Therapeutics Inc. (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
06/11/2025
3:35 PM | Ernexa Therapeutics Inc. (Filer)
Eterna Therapeutics (Filer)
Ernexa Therapeutics Inc. (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/15/2025
8:13 PM | Ernexa Therapeutics Inc. (Subject)
Eterna Therapeutics (Subject)
Ernexa Therapeutics Inc. (Subject)
HALPERN JOHN D (Filed by)
| Form SCHEDULE 13G/A | |
05/15/2025
3:42 PM | Ernexa Therapeutics Inc. (Subject)
Eterna Therapeutics (Subject)
Ernexa Therapeutics Inc. (Subject)
Konar Shameek (Filed by)
| Form SCHEDULE 13G | |
05/14/2025
7:39 PM | Ernexa Therapeutics Inc. (Subject)
Eterna Therapeutics (Subject)
Ernexa Therapeutics Inc. (Subject)
IAF, LLC (Filed by)
| Form SCHEDULE 13G/A | |
05/14/2025
1:14 PM | Ernexa Therapeutics Inc. (Subject)
Eterna Therapeutics (Subject)
Ernexa Therapeutics Inc. (Subject)
Freebird Partners LP (Filed by)
| Form SCHEDULE 13G/A | |
05/07/2025
10:48 AM | Cherington Charles (Reporting)
Ernexa Therapeutics Inc. (Issuer)
Eterna Therapeutics (Issuer)
Ernexa Therapeutics Inc. (Issuer)
| Form 4/A | |
04/29/2025
11:15 PM | Ernexa Therapeutics Inc. (Filer)
Eterna Therapeutics (Filer)
Ernexa Therapeutics Inc. (Filer)
| Form EFFECT | |
04/16/2025
3:30 PM | Ernexa Therapeutics Inc. (Filer)
Eterna Therapeutics (Filer)
Ernexa Therapeutics Inc. (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
Get the Latest News and Ratings for ERNA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Eterna Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
04/14/2025
4:05 PM | Ernexa Therapeutics Inc. (Filer)
Eterna Therapeutics (Filer)
Ernexa Therapeutics Inc. (Filer)
| Form ARS | |
04/04/2025
9:54 AM | Cherington Charles (Reporting)
Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics (Issuer)
Eterna Therapeutics Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2025
9:55 AM | Cherington Charles (Filed by)
Eterna Therapeutics Inc. (Subject)
Eterna Therapeutics (Subject)
Eterna Therapeutics Inc. (Subject)
| Form SCHEDULE 13D/A | |
04/03/2025
4:17 PM | Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
| Form PRE 14A | |
04/03/2025
7:55 AM | Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/26/2025
6:30 AM | Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/24/2025
3:30 PM | Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/12/2025
3:15 PM | Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/12/2025
3:20 PM | Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/05/2025
4:55 PM | Cherington Charles (Filed by)
Eterna Therapeutics Inc. (Subject)
Eterna Therapeutics (Subject)
Eterna Therapeutics Inc. (Subject)
| Form SCHEDULE 13D/A | |
02/14/2025
8:30 PM | Eterna Therapeutics Inc. (Subject)
Eterna Therapeutics (Subject)
Eterna Therapeutics Inc. (Subject)
Singer Nicholas Jason (Filed by)
| Form SCHEDULE 13G/A | |
02/14/2025
7:36 PM | Eterna Therapeutics Inc. (Subject)
Eterna Therapeutics (Subject)
Eterna Therapeutics Inc. (Subject)
HALPERN JOHN D (Filed by)
| Form SCHEDULE 13G/A | |
02/12/2025
4:54 PM | Eterna Therapeutics Inc. (Subject)
Eterna Therapeutics (Subject)
Eterna Therapeutics Inc. (Subject)
IAF, LLC (Filed by)
| Form SCHEDULE 13G/A | |
02/10/2025
6:00 PM | Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics (Issuer)
Eterna Therapeutics Inc. (Issuer)
Luther Sanjeev (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/10/2025
6:00 PM | Cicala Peter (Reporting)
Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics (Issuer)
Eterna Therapeutics Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/10/2025
6:00 PM | Bristol James Arthur (Reporting)
Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics (Issuer)
Eterna Therapeutics Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/10/2025
6:00 PM | Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics (Issuer)
Eterna Therapeutics Inc. (Issuer)
Gurrola Sandra M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/10/2025
6:00 PM | Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics (Issuer)
Eterna Therapeutics Inc. (Issuer)
Wexler William A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/28/2025
4:31 PM | Eterna Therapeutics Inc. (Subject)
Eterna Therapeutics (Subject)
Eterna Therapeutics Inc. (Subject)
Freebird Partners LP (Filed by)
| Form SCHEDULE 13G/A | |
01/14/2025
4:00 PM | Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics (Issuer)
Eterna Therapeutics Inc. (Issuer)
Ratner Elena (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/14/2025
4:01 PM | Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics (Issuer)
Eterna Therapeutics Inc. (Issuer)
Ratner Elena (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/18/2024
3:15 PM | Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
| Form 424B3 | |
11/18/2024
3:15 PM | Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
| Form 424B3 | |
11/18/2024
3:15 PM | Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
| Form 424B3 | |
11/17/2024
11:15 PM | Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
| Form EFFECT | |
11/14/2024
5:45 AM | Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
| Form D
Notice of Exempt Offering of Securities | |
11/14/2024
5:45 AM | Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
| Form D
Notice of Exempt Offering of Securities | |
11/05/2024
3:30 PM | Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
11/05/2024
11:42 AM | Cherington Charles (Reporting)
Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics (Issuer)
Eterna Therapeutics Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/29/2024
3:30 PM | Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
The Robotics Revolution has arrived … and one $7 stock could take off as a result. (Ad) Something big is brewing in Washington.
According to my research, an executive order from President Trump could be just weeks away.
And it holds the potential to trigger one of the most explosive tech booms in US history.
At the center of it all? Robots.
Not the kind that clean your house or pour you coffee.
But the kind that could reshape entire industries, add $1.2 trillion per year to the US economy, and affect 65 million American lives — just in the next year. This little-known company holds nearly 100 patents and trades for around $7 |
10/16/2024
3:15 PM | Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
| Form ARS | |
09/27/2024
3:47 PM | Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
| Form PRE 14A | |
09/27/2024
3:15 PM | Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/25/2024
3:36 PM | Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/23/2024
3:30 PM | Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/19/2024
4:00 PM | Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2024
3:30 PM | Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/25/2024
3:32 PM | Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics (Issuer)
Eterna Therapeutics Inc. (Issuer)
Gurrola Sandra M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Buy ERNA Stock Free ERNA Stock Alerts